Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megu Yamaguchi

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Plos One|December 15, 2015
Examination of a Viral Infection Mimetic Model in Human iPS Cell-Derived Insulin-Producing Cells and the Anti-Apoptotic Effect of GLP-1 AnalogueMegu Yamaguchi Baden, Kenji Fukui, Yoshiya Hosokawa, et al.
Internal Medicine (Tokyo, Japan)|November 2, 2011
Long-term efficacy of trilostane for Cushing's syndrome due to adrenocorticotropin-independent bilateral macronodular adrenocortical hyperplasiaYoshinari Obata, Yuya Yamada, Megu Yamaguchi Baden, et al.
Internal Medicine (Tokyo, Japan)|August 6, 2010
Long-term suppressive effect of octreotide on progression of metastatic gastrinoma with multiple endocrine neoplasia type 1: seven-year follow upMegu Yamaguchi, Yuya Yamada, Yoshiya Hosokawa, et al.
Clinical and Experimental Nephrology|December 1, 2011
Relationship between serum cystatin C and serum adiponectin level in type 2 diabetic patientsYoshiya Hosokawa, Yuya Yamada, Yoshinari Obata, et al.
Internal Medicine (Tokyo, Japan)|April 29, 2010
Lemierre syndrome with blepharoptosisMegu Yamaguchi, Hitoshi Nishizawa, Taku Yasumoto, et al.
Endocrine Journal|July 24, 2018
Factors associated with treatment satisfaction in patients with type 2 diabetes mellitus using oral glucose-lowering agents: a cross-sectional study in urban districts in JapanIsao Hayashi, Nobuaki Watanabe, Shinsuke Nakata, et al.
Journal of Diabetes Investigation|August 11, 2017
Insulin-producing cells derived from 'induced pluripotent stem cells' of patients with fulminant type 1 diabetes: Vulnerability to cytokine insults and increased expression of apoptosis-related genesYoshiya Hosokawa, Taro Toyoda, Kenji Fukui, et al.
Diabetology International|January 4, 2019
Risk factors for sudden death and cardiac arrest at the onset of fulminant type 1 diabetes mellitusMegu Yamaguchi Baden, Akihisa Imagawa, Hiromi Iwahashi, et al.
Diabetology International|February 26, 2019
Characteristics and clinical course of type 1 diabetes mellitus related to anti-programmed cell death-1 therapyMegu Yamaguchi Baden, Akihisa Imagawa, Norio Abiru, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Plos One|December 15, 2015
Examination of a Viral Infection Mimetic Model in Human iPS Cell-Derived Insulin-Producing Cells and the Anti-Apoptotic Effect of GLP-1 AnalogueMegu Yamaguchi Baden, Kenji Fukui, Yoshiya Hosokawa, et al.
Internal Medicine (Tokyo, Japan)|November 2, 2011
Long-term efficacy of trilostane for Cushing's syndrome due to adrenocorticotropin-independent bilateral macronodular adrenocortical hyperplasiaYoshinari Obata, Yuya Yamada, Megu Yamaguchi Baden, et al.
Internal Medicine (Tokyo, Japan)|August 6, 2010
Long-term suppressive effect of octreotide on progression of metastatic gastrinoma with multiple endocrine neoplasia type 1: seven-year follow upMegu Yamaguchi, Yuya Yamada, Yoshiya Hosokawa, et al.
Clinical and Experimental Nephrology|December 1, 2011
Relationship between serum cystatin C and serum adiponectin level in type 2 diabetic patientsYoshiya Hosokawa, Yuya Yamada, Yoshinari Obata, et al.
Internal Medicine (Tokyo, Japan)|April 29, 2010
Lemierre syndrome with blepharoptosisMegu Yamaguchi, Hitoshi Nishizawa, Taku Yasumoto, et al.
Endocrine Journal|July 24, 2018
Factors associated with treatment satisfaction in patients with type 2 diabetes mellitus using oral glucose-lowering agents: a cross-sectional study in urban districts in JapanIsao Hayashi, Nobuaki Watanabe, Shinsuke Nakata, et al.
Journal of Diabetes Investigation|August 11, 2017
Insulin-producing cells derived from 'induced pluripotent stem cells' of patients with fulminant type 1 diabetes: Vulnerability to cytokine insults and increased expression of apoptosis-related genesYoshiya Hosokawa, Taro Toyoda, Kenji Fukui, et al.
Diabetology International|January 4, 2019
Risk factors for sudden death and cardiac arrest at the onset of fulminant type 1 diabetes mellitusMegu Yamaguchi Baden, Akihisa Imagawa, Hiromi Iwahashi, et al.
Diabetology International|February 26, 2019
Characteristics and clinical course of type 1 diabetes mellitus related to anti-programmed cell death-1 therapyMegu Yamaguchi Baden, Akihisa Imagawa, Norio Abiru, et al.
Pageof 1